Showing results (561-570 of 587) with videos related to

Sort By:
Pageof 59
Journal of Medicinal Chemistry|January 5, 2007
Development of dihydropyridone indazole amides as selective Rho-kinase inhibitorsKrista B Goodman, Haifeng Cui, Sarah E Dowdell, et al.
JCO Precision Oncology|January 23, 2023
Clinicopathologic and Molecular Analysis of Normal Karyotype Therapy-Related and De Novo Acute Myeloid Leukemia: A Multi-Institutional Study by the Bone Marrow Pathology GroupMiguel D Cantu, Rashmi Kanagal-Shamanna, Sa A Wang, et al.
Blood Advances|January 10, 2020
PD-1 blockade for diffuse large B-cell lymphoma after autologous stem cell transplantationMatthew J Frigault, Philippe Armand, Robert A Redd, et al.
International Journal of Cancer|September 11, 2020
Causal relationships between body mass index, smoking and lung cancer: Univariable and multivariable Mendelian randomizationWen Zhou, Geoffrey Liu, Rayjean J Hung, et al.
Journal of Clinical and Experimental Hepatology|December 18, 2023
2023 Update of Indian National Association for Study of the Liver Consensus on Management of Intermediate and Advanced Hepatocellular Carcinoma: The Puri III RecommendationsAshish Kumar, Subrat K Acharya, Shivaram P Singh, et al.
Neurosurgical Focus|May 2, 2020
Transforming Research and Clinical Knowledge in Spinal Cord Injury (TRACK-SCI): an overview of initial enrollment and demographicsRachel E Tsolinas, John F Burke, Anthony M DiGiorgio, et al.
Research Square|August 20, 2025
Genes associated with genetic and rare lung diseases and the risk of lung cancerAlbert Rosenberger, Heike Bickeböller, David C Christiani, et al.
American Journal of Human Genetics|May 5, 2009
Mutations in smooth muscle alpha-actin (ACTA2) cause coronary artery disease, stroke, and Moyamoya disease, along with thoracic aortic diseaseDong-Chuan Guo, Christina L Papke, Van Tran-Fadulu, et al.
Genome Medicine|February 5, 2024
Impact of individual level uncertainty of lung cancer polygenic risk score (PRS) on risk stratificationXinan Wang, Ziwei Zhang, Yi Ding, et al.
Journal of Medicinal Chemistry|January 5, 2007
Discovery of aminofurazan-azabenzimidazoles as inhibitors of Rho-kinase with high kinase selectivity and antihypertensive activityRobert A Stavenger, Haifeng Cui, Sarah E Dowdell, et al.
Pageof 59